Key PointsSold 6,430 shares of Eli Lilly and Company; estimated transaction value ~$4.78 millionPost-trade holding: 61,292 shares valued at $46.77…
The rapid growth rates of recent years arent guaranteed to continue.…
Eli Lilly and Co (NYSE:LLY) will report its third quarter 2025 earnings next Thursday, with Bank of America analysts closely…
Eli Lilly and Co (NYSE:LLY) will report its third quarter 2025 earnings next Thursday, with Bank of America analysts closely…
Key PointsIncreased position by 259,392 shares in Q3 2025; estimated $193.03 million trade based on the average price during Q3…
Novo Nordisk and Eli Lilly shares fell after President Donald Trump said the price of the blockbuster diabetes drug Ozempic could come down to just…
Eli Lilly and Novo Nordisk shares dropped after President Donald Trump said he wants a $150 price tag for GLP-1s.…
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.5% in the afternoon session after political comments introduced significant uncertainty…
Trumps pledge to slash GLP-1 drug prices sends Novo Nordisk and Eli Lilly shares tumbling, raising questions about the feasibility…
Trump’s comments on Ozempic “signal aggressive posturing” in drug price negotiations, an analyst said…
American Express, Truist Financial and Fifth Third rise premarket; Eli Lilly falls…
Cantor Fitzgerald maintains Eli Lilly stock rating despite orforglipron setback…
US equity futures decline, Treasuries extend rally and the dollar stays on track for its biggest weekly drop since July.…
Shares of Novo Nordisk (NYSE:NVO) and Eli Lilly and Co (NYSE:LLY), two major pharmaceutical companies that produce weight-loss drugs, dropped…
These stocks have climbed in the triple digits over the past few years.…
Shares of Eli Lilly and Novo Nordisk move lower in Thursdays after-hours session after President Trump indicated weight-loss drugs are…
Key PointsChesapeake sold 9,875 Eli Lilly and Company shares; estimated trade value of approximately $7.68 million, based on the average…
The smaller drugmaker is looking to disrupt a fast-growing market.…
Eli Lilly (LLY) concluded the recent trading session at $826.57, signifying a +1.75% move from its prior days close.…
…
Strong sector performers stand out as AAPL, LLY, and V gain traction through services, drug demand, and digital payment growth.…
Apples strong Services growth, Eli Lillys GLP-1 momentum, and Visas digital expansion headline todays top stock reports.…
…
The company is readying to take on pharma giants Novo Nordisk and Eli Lilly.…
Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after…
The Gates Foundation and the Pan American Health Organization are both working on ways to make weight-loss drugs like Novo…
Eli Lilly (LLY) reached $855.35 at the closing of the latest trading day, reflecting a +1.14% change compared to its…
Lilly Endowment sells $137 million in Eli Lilly shares…
After nearly two years of sideways price action, Eli Lilly stock could soar to new highs between now and 2030.…
Eli Lilly (LLY) plans to invest more than $1B in India in the coming years to boost manufacturing and supply…
LLY shares have jumped 16% last week as Pfizers landmark government deal boosted investor confidence across the pharma sector.…
Eli Lilly is riding a big trend.…
Eli Lilly will invest more than $1 billion in India in the coming years to boost manufacturing and supply through…
Eli Lilly (LLY) closed the most recent trading day at $839.87, moving +2.44% from the previous trading session.…
Eli Lilly (LLY) closed the most recent trading day at $839.87, moving +2.44% from the previous trading session.…
Pfizers deal with the Trump administration raised hopes that Eli Lilly would also avoid pharmaceutical tariffs.…
In the past week, a U.S. federal judge dismissed Eli Lillys lawsuit against Willow Health, a telehealth competitor to Hims…
Market Analysis by covering: Eli Lilly and Company, Merck & Company Inc, Pfizer Inc, AbbVie Inc. Read s Market…
What Happened? A number of stocks jumped in the afternoon session after news of a new government prescription drug policy…
Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its…
Here are the stocks that made the biggest moves today.…
Eli Lilly, Merck Lead Market Cap Stock Movers on Wednesday…
Pharmaceutical stocks gained Wednesday afternoon amid anticipation Pfizers deal with the Trump administration could lead to more with other firms.…
Earlier this year, Eli Lilly had initiated a lawsuit against Willow Health along with three other telehealth companies concerning the…
…
The pharmaceutical company had a clinical setback earlier this year, but thats now in the rearview mirror.…
Eli Lilly secures EU approval for Alzheimers drug Kisunla and gains FDA nod to breast cancer therapy Inluriyo.…
…
Bloomberg journalists discuss todays biggest winners and losers in the stock market. Listen for analysis on the companies making news…
Eli Lillys diversified pipeline, rapid tirzepatide growth and rising estimates give it the edge over Novo Nordisk in the obesity…